Ellagic acid enhances the anti-nociceptive effects of cyclooxygenase inhibitors in a mouse visceral pain model

authors:

avatar Masumeh Abbasi 1 , avatar Mohammad Taghi Mansouri 2 , 3 , * , avatar Bahareh Naghizadeh 4 , avatar Behnam Ghorbanzadeh 5

School of Medicine, Arvand Branch, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Department of Pharmacology, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Neuroanesthesia Laboratory, Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA, USA
Department of Pharmacology, School of Pharmacy, Pain Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Department of Pharmacology, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran

how to cite: Abbasi M, Mansouri M T, Naghizadeh B, Ghorbanzadeh B. Ellagic acid enhances the anti-nociceptive effects of cyclooxygenase inhibitors in a mouse visceral pain model. Jundishapur J Physiol. 2018;1(1):e148265. 

Abstract

Introduction: Combination therapies have long been used to treat painful conditions while reducing side effects. Recently, we have reported the central and peripheral antinociceptive effects of ellagic acid (a polyphenol compound in pomegranates, grapes and different berries). The present study aimed to evaluate the therapeutic potential of combination treatment with ellagic acid (EA) and nonsteroidal anti-inflammatory drugs (NSAIDs) in a visceral model of pain.
Materials and Methods: The abdominal writhing test was selected as a model of visceral inflammatory pain. Different doses of EA, indomethacin, celecoxib and acetaminophen alone or in combination with EA were administered.
Results: Data showed that EA at doses 1–10 mg/kg i.p. significantly reduced the writhes’ number induced by acetic acid in mice. Moreover, intraperitoneal administration of indomethacin at 3, 10 mg/kg, celecoxib at 10, 30 mg/kg, and acetaminophen at 200, 300 mg/kg, significantly reduced the writhing reaction. On the other hand, combination of sub-effective dose of EA (0.3 mg/kg; i.p.) with sub-analgesic doses of indomethacin (0.3, 1 mg/kg; i.p.), celecoxib (1, 3 mg/kg; i.p.) and acetaminophen (60, 100 mg/kg; i.p.) significantly decreased the number of writhes as compared to the per se effect.
Conclusions: These results indicate that EA markedly potentiates the antinociceptive activity of NSAIDs in visceral pain model. Further, these results suggest that the described combination therapies would be effective as an alternative to conventional NSAIDs and may lower incidence of their adverse effects.